Life MD Facebook ad: “Struggling to Lose Weight? LifeMD Can Help!”

Ran for 3 days, from February 19 to February 22, 2026, the last day Crush saw it.
Run by Life MD on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1206717778283705
- Platforms
- Facebook, Instagram, Messenger and Threads
- Relaunches
- 0
- Niche
- Insurance
Ad text
Don't wait to reach your health goals. Here’s how LifeMD can help: Here’s how LifeMD can help you on your journey: ✅ 50% OFF the Weight Management Program ⚕️ Access to GLP-1 injections like Wegovy and Zepbound* (prescribed)* ☑️ Insurance verification check to maximize savings—plans can start as low as $0 copay 👨🏼⚕️ Ongoing virtual care from licensed U.S. healthcare providers 📥 24/7 patient support from a dedicated care team Join over 50,000 patients who have trusted LifeMD to guide their weight loss journey—all from the comfort of home. 👉🏼 See if you qualify today: https://social.lifemd.com/Weight Disclosure: Eligibility and results may vary. Do not use if you or your family have a history of a type of thyroid cancer called MTC (medullary thyroid carcinoma) or MEN 2 (multiple endocrine neoplasia syndrome). *Individual results may vary. 15% body weight loss based on the average weight loss in three 68-week clinical trials of patients on Wegovy without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity. In a 72-week Zepbound (tirzepatide) study of adults without diabetes, average weight loss was 15.0% (34 lbs) for 5 mg, 19.5% (44 lbs) for 10 mg, 20.9% (48 lbs) for 15 mg, and 3.1% (7 lbs) for placebo.
Where the ad sends people
rx.lifemd.com
Struggling to Lose Weight? LifeMD Can Help!
Learn more: track.trklfmd.com(opens in a new tab)









